The Xp11 RCCs (TFE3-tRCC) were first described in 1991 by Tomlinson et al. in a 17-month-old child and considered as “juvenile RCC” [6]. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.